Apr 10, 2017 - Roche (RHHBY) announced that the global, randomized phase III study, ALEX, on lung cancer drug Alecensa met its primary endpoint as an initial (first-line) treatment.
Apr 07, 2017 - Nepsis Capital Management, Inc. Buys STMicroelectronics NV, Cisco Systems, ArcelorMittal SA, Sells Nutanix, Wal-Mart Stores, Ventas, Stocks: RIO,FFIV,STM,CSCO,MT,TWLO,CHKP,AXS,NTNX,WMT,AIRG,, release date:Apr 07, 2017
Mar 31, 2017 - Two drugs with blockbuster potential - Sanofi (SNY)/Regeneron's Dupixent and Roche's Ocrevus - gained FDA approval this week.
Mar 30, 2017 - Novartis A.G. (NVS) announced that the FDA has accepted and granted priority review designation to its biologics license application (BLA) for pipeline candidate, CTL019 (tisagenlecleucel-T).
Mar 28, 2017 - AEB has reached levels where the upside potential is limited by its fundamentals.Floating Rate preferred stocks have had a good year so far, but at some point it is wise to cash in.There are other opt
Mar 27, 2017 - Leucadia National Buys Lonestar Resources US, NXP Semiconductors NV, Deutsche Bank AG, Sells Procter & Gamble Co, Coty, SPDR S&P 500, Stocks: LONE,NXPI,DB,LVLT,JNS,TLT,SINA,SPY,WR,PG,COTY,GLD,, release date:Mar 27, 2017
Mar 27, 2017 - Johnson & Johnson (JNJ) announced that the French health authority has granted approval to expand the label of Eprex to include treatment of symptomatic anaemia in patients with low or intermediate risk myelodysplastic syndromes (MDS).
Mar 24, 2017 - The following slide deck was published by TiGenix NV (NYSE:ADS) in conjunction with this event.
Mar 24, 2017 - The Zacks Analyst Blog Highlights: Milacron Holdings, Galapagos NV and Raymond James Financial
Mar 24, 2017 - This week's highlights include rumors regarding Sanofi (SNY) acquiring Flexion, accelerated FDA approval for a Pfizer/Merck KGaA drug and drug pricing.